brand logo

Am Fam Physician. 2000;62(9):1967

The article “Successful Management of the Obese Patient” (June 15, 2000, page 3615) contained an error in Table 1 (page 3618). Orlistat (Xenical) is incorrectly listed as a DEA schedule IV medication; orlistat does not have a DEA listing. The corrected table is reprinted below. An error was also made in the biography; Dr. Poston is co-director of behavioral cardiology research, not of the residency program.

AgentDEA scheduleAction
Diethylpropion (Tenuate)IVNoradrenergic
Mazindol (Sanorex)IVNoradrenergic
Orlistat* (Xenical)Lipase inhibitor
Phendimetrazine (Plegine)IIINoradrenergic
Phentermine (Fastin)IVNoradrenergic
Phentermine resin (Ionamin)IVNoradrenergic
Phenylpropanolamine (Dexatrim)OTCNoradrenergic
Sibutramine* (Meridia)IVSNRI

Continue Reading


More in AFP

Copyright © 2000 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See https://www.aafp.org/about/this-site/permissions.html for copyright questions and/or permission requests.